If symptoms persist or worsen despite investigation and management of identified causes, discuss with your diabetes specialist whether continuing Mounjaro remains appropriate or whether alternative treatments should be considered
And it turns out much of this is not strictly weight loss dependent. In the SELECT cardiovascular outcomes trial published in November 2023, semaglutide was associated with a 20% risk reduction in major adverse cardiovascular events in patients 45 years of age or older compared with placebo
That said, general recommendations are a good start, but daily water needs vary from person to person
Increase fiber gradually and maintain fluid intake when addressing constipation
References Mutsaers HAM, Merrild C, Norregaard R, Plana-Ripoll O
Cost-effectiveness acceptability curve